Wang C, Lishner M, Minden M D, McCulloch E A
Ontario Cancer Institute, University of Toronto, Canada.
Leukemia. 1990 Aug;4(8):548-52.
Leukemia inhibitory factor (LIF) was tested using three established acute myelocytic leukemia (AML) cell lines. In growth assays in two of the three lines, we found that the addition of LIF increased the doubling time of the clonogenic population but not the total population as assessed by nucleated cell counts. Similarly, tritiated thymidine uptake into total AML populations was not affected by LIF, but the percentage of clonogenic cells killed by exposure to high specific activity 3HTdR was reduced in LIF-treated cultures compared to controls. We interpret these results to indicate that LIF prolongs the cell cycle of stem cells in some AML lines, possibly by increasing the time spent in the G2-M-G1 parts of the cycle. Consistent with this interpretation, we observed a decrease in ara-C sensitivity in LiF treated cultures. Variable results were obtained when freshly obtained AML blasts were exposed to LIF.
使用三种已建立的急性髓细胞白血病(AML)细胞系对白血病抑制因子(LIF)进行了检测。在三个细胞系中的两个细胞系的生长试验中,我们发现添加LIF会增加克隆形成群体的倍增时间,但不会增加通过有核细胞计数评估的总群体的倍增时间。同样,LIF对AML总群体中氚标记胸腺嘧啶核苷的摄取没有影响,但与对照组相比,在LIF处理的培养物中,暴露于高比活3HTdR后被杀死的克隆形成细胞的百分比降低。我们将这些结果解释为表明LIF可能通过增加细胞周期中G2-M-G1部分所花费的时间来延长某些AML细胞系中干细胞的细胞周期。与这种解释一致,我们观察到在LIF处理的培养物中阿糖胞苷敏感性降低。当将新鲜获得的AML原始细胞暴露于LIF时,获得了不同的结果。